eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/10/2011
PIL Lescol (fluvastatin* sodium) 20 mg and 40 mg capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 15/09/2010 and displayed until 11/10/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 08/12/2009 and displayed until 15/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/03/2009 and displayed until 08/12/2009
Reasons for adding or updating:
  • Change of contra-indications
Updated on 13/02/2009 and displayed until 25/03/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 28/09/2007 and displayed until 13/02/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 16/01/2007 and displayed until 28/09/2007
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to drug interactions
Updated on 06/01/2005 and displayed until 16/01/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to drug interactions
Updated on 21/08/2003 and displayed until 06/01/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 29/08/2002 and displayed until 21/08/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 14/11/2000 and displayed until 29/08/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  fluvastatin sodium